Ergo Science Corp
OTC:ERGN
Intrinsic Value
Ergo Science Corp. engages in the provision of business information. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of ERGN.
Ergo Science Corp's market capitalization is 55.2B USD.
ERGN stock price is 10 800 USD.
ERGN.
ERGN. Open DCF Valuation
ERGN. Open Relative Valuation
ERGN.
ERGN's short-term assets (11m USD) exceed its short-term liabilties (11m USD).
ERGN's ROIC (Return on Invested Capital) has increased in the last 3 years from -20% to -19%, and is approaching profitability.
ERGN's ROE (Return on Equity) has increased in the last 3 years from -25% to -23%, and is approaching profitability.
ERGN has negative Free Cash Flow for the last twelve months.
ERGN has positive Gross Profit for the last twelve months.
ERGN has negative Operating Income for the last twelve months.
ERGN has negative Net Income for the last twelve months.
ERGN's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -19%.
ERGN's ROE (Return on Equity) for the past 12 months is negative and is equal to -23%.
ERGN's long-term assets (28m USD) exceed its long-term liabilties (11m USD).
ERGN has negative three-year average ROE (Return on Equity): -10%. The company is not efficient at transforming stockholders' equity into net income.
ERGN has negative three-year average ROIC (Return on Invested Capital): -1 555%. The company is not efficient at using invested capital to generate operating income.
ERGN's D/E (Debt to Equity) is very low and is equal to 0.
ERGN's Altman Z-Score is very low and is equal to -4.61.
Fundamental Analysis
Ergo Science Corp
Balance Sheet Decomposition
Ergo Science Corp
| Current Assets | 10.9m |
| Cash & Short-Term Investments | 3.5m |
| Other Current Assets | 7.4m |
| Non-Current Assets | 17.2m |
| PP&E | 4.3m |
| Intangibles | 4.3m |
| Other Non-Current Assets | 8.5m |
| Current Liabilities | 10.8m |
| Other Current Liabilities | 10.8m |
Earnings Waterfall
Ergo Science Corp
|
Revenue
|
25.6m
USD
|
|
Cost of Revenue
|
-17.5m
USD
|
|
Gross Profit
|
8.1m
USD
|
|
Operating Expenses
|
-13.4m
USD
|
|
Operating Income
|
-5.3m
USD
|
|
Other Expenses
|
1m
USD
|
|
Net Income
|
-4.3m
USD
|
Free Cash Flow Analysis
Ergo Science Corp
ERGN Profitability Score
Profitability Due Diligence
Ergo Science Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Ergo Science Corp's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
ERGN Solvency Score
Solvency Due Diligence
Ergo Science Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Ergo Science Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ERGN Price Targets Summary
Ergo Science Corp
Shareholder Return
ERGN Price
Ergo Science Corp
| Average Annual Return | 2.94% |
| Standard Deviation of Annual Returns | 4.16% |
| Max Drawdown |
N/A
|
| Market Capitalization | 55.2B USD |
| Shares Outstanding | 5 114 040 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Ergo Science Corp
Country
Industry
Market Cap
Dividend Yield
Description
Ergo Science Corp. engages in the provision of business information. The company is headquartered in Stow, Massachusetts. In addition to core magazine brands, Ergo also provides services, which include exhibitions, conferences, awards ceremony events and online services. The firm's business includes 13 trade names; 150 domain names; approximately 50 printed magazines and directories, and approximately 30 Events, including exhibitions, awards evenings and conferences.
You don't have any saved screeners yet
